Fragment-Based Drug Discovery
Authors:
- Venkata VelvadapuVVVenkata Velvadapu
- Bennett T. FarmerBFBennett T. Farmer
- Allen B. ReitzARAllen B. Reitz
- 1 January 2015
- book chapter
- Published by Elsevier
- p. 161-180
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Pyrrolamide DNA Gyrase Inhibitors: Fragment-Based Nuclear Magnetic Resonance Screening To Identify Antibacterial AgentsAntimicrobial Agents and Chemotherapy, 2012
- Route to three-dimensional fragments using diversity-oriented synthesisProceedings of the National Academy of Sciences, 2011
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanomaNature, 2010
- Profiling the NIH Small Molecule Repository for Compounds That Generate H 2 O 2 by Redox Cycling in Reducing EnvironmentsASSAY and Drug Development Technologies, 2010
- Discovery and development of heat shock protein 90 inhibitorsBioorganic & Medicinal Chemistry, 2009
- A Novel Class of Small Molecule Inhibitors of Hsp90ACS Chemical Biology, 2008
- Perspectives on NMR in drug discovery: a technique comes of ageNature Reviews Drug Discovery, 2008
- Development of a 384-Well Colorimetric Assay to Quantify Hydrogen Peroxide Generated by the Redox Cycling of Compounds in the Presence of Reducing AgentsASSAY and Drug Development Technologies, 2008
- Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activityProceedings of the National Academy of Sciences, 2008
- A detergent-based assay for the detection of promiscuous inhibitorsNature Protocols, 2006